Answer
Ripretinib (QINLOCK) is suspected to harm an unborn baby based on its mechanism and animal reproductive toxicity findings; there are no pregnancy data in humans, and it should not be used during pregnancy unless the woman’s clinical condition requires treatment.
Sources for this answer
- QINLOCK 50 mg tabletsDeciphera · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked